title: Beta-blockers and non-cardiac operations what will change after the POISE study?: ?qué cambia después del estudio POISE?
authors.affiliation: Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. danigualandro@cardiol.br
authors.forename: Danielle Menosi
authors.initials: DM
authors.lastname: Gualandro
authors.forename: Daniela
authors.initials: D
authors.lastname: Calderaro
authors.forename: Pai Ching
authors.initials: PC
authors.lastname: Yu
authors.forename: Andre Coelho
authors.initials: AC
authors.lastname: Marques
authors.forename: Bruno
authors.initials: B
authors.lastname: Caramelli
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage / Q000009:adverse effects; D009203:Myocardial Infarction / Q000517:prevention & control; D019990:Perioperative Care / Q000379:methods / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000139:chemically induced; D013514:Surgical Procedures, Operative / Q000379:methods*
chemical_list: D000319:Adrenergic beta-Antagonists; D008790:Metoprolol